Literature DB >> 2405011

Immunophysical characterization of human isolates of Serratia marcescens.

R M Hamadeh1, R E Mandrell, J M Griffiss.   

Abstract

The immunophysical characteristics of 29 Serratia marcescens strains isolated from hospitalized patients in three different cities were studied. Their outer membrane antigens were compared by solid-phase radioimmunoassay inhibition, and their proteinase K-treated, whole-cell lysates were compared by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis. The strains had a limited number of unique outer membrane lipopolysaccharide (LPS) and capsular polysaccharide (K) antigens. By solid-phase radioimmunoassay inhibition, these strains could be divided into four distinct LPS and five K antigenic groups. By SDS-PAGE, the LPS groups could be further divided into three distinct SDS-PAGE core polysaccharide profiles and five distinct O-side-chain polysaccharide profiles. Immunoblot analysis with rabbit antiserum confirmed the limited heterogeneity of these isolates. Of the strains tested, no PAGE profile was unique to blood or nonblood isolates or to organisms collected from a given hospital. Variability of O and core PAGE profiles was not a function of organism growth cycle. Five representative Serratia strains were tested by SDS-PAGE and immunoblot analysis and in a bactericidal assay with normal human serum. We found that (i) the normal human serum had antibodies to the LPS of each of the strains, (ii) the anti-LPS antibody measured by immunoblot did not correlate with the level of bactericidal activity in the normal human serum, (iii) three of four sepsis isolates were serum sensitive, (iv) two Serratia strains serum sensitive in log-phase growth became serum resistant in late stationary-phase growth and under limiting nutrient conditions, and (v) no LPS PAGE profile distinguished serum-sensitive from serum-resistant strains.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405011      PMCID: PMC269530          DOI: 10.1128/jcm.28.1.20-26.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Sensitization of complement-resistant smooth gram-negative bacterial strains.

Authors:  B L Reynolds; H Pruul
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

2.  The analysis of lipopolysaccharide (endotoxin) in meningococcal polysaccharide vaccines by silver staining following SDS-polyacrylamide gel electrophoresis.

Authors:  C M Tsai
Journal:  J Biol Stand       Date:  1986-01

3.  Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes.

Authors:  J J Kim; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.

Authors:  M S Simberkoff; I Ricupero; J J Rahal
Journal:  J Lab Clin Med       Date:  1976-02

6.  [New antigenic factors, O (O23) and H (H26), of Serratia marcescens].

Authors:  S Le Minor; F Benazet; L Martin
Journal:  Ann Microbiol (Paris)       Date:  1983 Nov-Dec

7.  Response to antigenic determinants of Neisseria meningitidis lipopolysaccharide investigated with a new radioactive antigen-binding assay.

Authors:  M A Bertram; J M Griffiss; D D Broud
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

8.  The sensitivity to complement of strains of Escherichia coli related to their K antigens.

Authors:  A A Glynn; C J Howard
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

9.  Effect of the growth environment on cell-envelope components of Escherichia coli in relation to sensitivity to human serum.

Authors:  P W Taylor; P Messner; R Parton
Journal:  J Med Microbiol       Date:  1981-02       Impact factor: 2.472

10.  Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more
  4 in total

1.  Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.

Authors:  R M Hamadeh; G A Jarvis; U Galili; R E Mandrell; P Zhou; J M Griffiss
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

2.  Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing.

Authors:  R M Hamadeh; M M Estabrook; P Zhou; G A Jarvis; J M Griffiss
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

3.  Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.

Authors:  B W Gibson; W Melaugh; N J Phillips; M A Apicella; A A Campagnari; J M Griffiss
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

4.  Bacterial enzymes can add galactose alpha 1,3 to human erythrocytes and creates a senescence-associated epitope.

Authors:  R M Hamadeh; G A Jarvis; P Zhou; A C Cotleur; J M Griffiss
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.